What Pandemic Effect? US FDA’s 2021 Approval Class Is Off To Strong Start With 60+ Novel Candidates

 
• By Bridget Silverman
  
High corn crops on a row
The US FDA may have a bumper crop of new drug approvals this year.

More from Approvals

More from Product Reviews